Search clinical trials for: SOM230 LAR,
Total 420 results
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
Novartis PharmaceuticalsCompletedDumping SyndromeBelgium, Netherlands, Germany, France, United States
-
Lynn FeunCompletedHepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedCastration Resistant Prostate CancerGermany
-
Mayo ClinicCompletedAutosomal Dominant Polycystic Kidney Disease | Polycystic Liver Disease | Autosomal Dominant Polycystic Liver Disease | Somatostatin AnalogsUnited States
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
University of PittsburghNovartisWithdrawnMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
-
University of PennsylvaniaTerminatedGonadotroph AdenomasUnited States
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Pituitary GigantismJapan
-
Prof. Dr. Berthold SchalkeCrolll GmbhCompletedPrimary Inoperable Thymoma | Local Recurrent ThymomaGermany
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
Novartis PharmaceuticalsApproved for marketing
-
Riphah International UniversityRecruiting
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingAging | Functional Disturbance | Home
-
University of Campinas, BrazilCompletedFrailty | Blood PressureBrazil
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Centre Hospitalier Universitaire VaudoisCompletedPalliative Care | Hypnosis | HomeSwitzerland
-
Centre Francois BaclesseTerminatedCancer | Palliative Care | HomeFrance
-
Aveiro UniversityCompleted
-
Erasmus Medical CenterNovartisUnknown
-
Centre Hospitalier Universitaire, AmiensCentre Hospitalier de Beauvais; Hopital Charles Nicolle; Centre Hospitalier de... and other collaboratorsRecruitingFall | Home | Intelligent Video Surveillance | Frail Elderly PersonFrance
-
Azidus BrasilSuspended
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
University GhentUniversiteit AntwerpenCompleted
-
The University of Hong KongCompletedOlder Adults | Family Members | Nursing HomeHong Kong
-
Assiut UniversityUnknownAnorectal Malformation
-
Aveiro UniversityCompletedChronic PainPortugal
-
Columbia UniversityNovartisUnknown
-
Gérond'ifTerminatedCardiac Pathology | Residents of Retirement Home (EHPAD)France
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedEverolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Canada, Italy, Belgium, Turkey, Spain, France, Denmark, Germany, Greece, Israel, Argentina, China, Portugal, Brazil, Mexico, Finland, Poland
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Providence VA Medical CenterUS Department of Veterans AffairsUnknownVeterans | Nursing Home | Quality of Care | Functional Impairment
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States, Italy, Belgium, Saudi Arabia, Spain, France, Germany, Canada, United Kingdom, Colombia, Brazil, Israel, Turkey, Romania, Norway, Poland, Russian Federation, Argentina
-
Federico II UniversityUniversity of Genova; University Hospital, Udine, Italy; University of Perugia...CompletedGastrointestinal Neoplasms | Respiratory Tract Neoplasms | Pancreatic Neoplasms | Multiple Endocrine Neoplasia | Thymic NeoplasmsItaly
-
End-of-Life Research GroupCompletedElderly Care | Advance Care Planning | Nursing HomeBelgium
-
Haukeland University HospitalUniversity of Bergen; Helse Stavanger HF; Helse Vest; Forskningsrådet; Folkehelse... and other collaboratorsActive, not recruitingHepatitis C, Chronic | Opioid Dependence, on Agonist TherapyNorway
-
Haukeland University HospitalUniversity of Bergen; Helse Stavanger HF; Helse VestActive, not recruitingSubstance-Related Disorders | Smoking CessationNorway
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Carcinoid TumorGermany, Belgium, Canada, Netherlands, United States, Norway
-
Radboud University Medical CenterSt. Antonius HospitalUnknownAnemia | Gastrointestinal Hemorrhage | Hereditary Hemorrhagic TelangiectasiaNetherlands
-
Novartis PharmaceuticalsCompleted
-
Academia Cearense de OdontologiaCompletedOral Health | Public Health | Diagnosis, OralBrazil
-
Mario Negri Institute for Pharmacological ResearchOtsuka Pharmaceutical Italy S.r.l.CompletedAutosomal Dominant Polycystic Kidney DiseaseItaly
-
Endo PharmaceuticalsCompleted